Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of April 6, 2026, Pliant Therapeutics Inc. (PLRX) trades at $1.36, posting a mild 0.74% gain on the session. This analysis focuses on key technical levels and market dynamics shaping the biotech stock’s near-term trading activity, as no recent earnings data is available for the company at this time. PLRX, which focuses on developing novel therapies for fibrotic diseases, has traded in a tight range in recent weeks, with price action largely driven by broader sector sentiment and technical tra
Is Pliant Therapeutics (PLRX) Stock Lagging the Market | Price at $1.36, Up 0.74% - Trading Community
PLRX - Stock Analysis
4162 Comments
941 Likes
1
Latechia
Regular Reader
2 hours ago
I need a support group for this.
👍 45
Reply
2
Larhea
Elite Member
5 hours ago
Comprehensive US stock balance sheet stress testing and liquidity analysis for downside risk assessment and crisis preparedness planning. We model different scenarios to understand how companies would perform under adverse conditions and economic stress. We provide stress testing, liquidity analysis, and downside scenario modeling for comprehensive coverage. Understand downside risks with our comprehensive stress testing and liquidity analysis tools for risk management.
👍 180
Reply
3
Kanajah
Registered User
1 day ago
Exceptional results, well done!
👍 284
Reply
4
Jaculine
Daily Reader
1 day ago
Positive technical signals indicate further upside potential.
👍 161
Reply
5
Shanyel
Daily Reader
2 days ago
This feels like something is repeating.
👍 166
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.